Cellink LLC

Cellink LLC, a foreign-owned for-profit biotech company headquartered in Blacksburg, Virginia, supplies advanced biomedical research equipment—principally 3D bioprinters, robotic liquid handling systems, and automated cell culture platforms—to federal civilian agencies as a prime contractor on purchase orders. The vendor operates exclusively in the full-and-open competitive space with no set-aside designations across its recent federal footprint, though two older awards (2022) carried total small business set-asides. Cellink's portfolio spans 31 prime awards totaling $2.6 million in combined potential value, with $2.5 million obligated (98% of potential value), across sixteen customer agencies since 2016.

Customer concentration sits with the National Institutes of Health and its component institutes. The top five funding entities by count account for 55% of awards: the NIH National Institute on Deafness and Other Communication Disorders (five awards, $89 thousand combined potential value), the National Institute of Standards and Technology (three awards, $229 thousand), the Environmental Protection Agency (three awards, $75 thousand), the FDA (three awards, $111 thousand), and the NCI (three awards, $222 thousand). When ranked by potential value, the top five by dollars yield a different emphasis: the NIH National Institute on Aging leads with one $367 thousand award for a robotic single-cell printer with washing station, followed by the National Center for Advancing Translational Sciences (three awards, $261 thousand), NIST (three awards, $229 thousand), the NCI (three awards, $222 thousand), and the VA Veterans Integrated Service Network 21 (two awards, $208 thousand). The concentration gap signals that NIDCD places numerous smaller maintenance and support-service orders while NIA anchors a single large equipment delivery.

Work product is entirely equipment procurement and related support. Named recent examples include a $367 thousand F.SIGHT robotic single-cell printer with washing station from the NIH National Institute on Aging (September 2022), a $194 thousand BIO X Series 3D bioprinters and I-DOT liquid handling systems order from the NIH Office of Logistics and Acquisition Operations (September 2022), a $170 thousand BIODISPENSER 3D printer order from the VA Veterans Integrated Service Network 21 (July 2024), a $206 thousand microbial single-cell isolation system from the Office of Naval Research (September 2023), and recurring annual service contracts with NIDCD for premium customer care packages and maintenance for F.SIGHT platforms running $16 thousand to $25 thousand per year. The most recent award, dated September 3, 2026, is a $64 thousand purchase order from the National Cancer Institute for advanced 3D culture systems and organoid models to support tumor research, completing September 2, 2027. A $62 thousand multi-year NCI sole-source maintenance contract for a government-owned I-DOT One dispensing system runs through June 2, 2025. NAICS concentration reflects equipment manufacturing: 13 awards under Analytical Laboratory Instrument Manufacturing, 7 under Printing Machinery and Equipment Manufacturing, and 7 under Research and Development in Biotechnology.

Activity trajectory is declining. Seven awards in 2022 fell to three in 2023, five in 2024, two in 2025, and one in 2026. Two awards (combined potential value $98 thousand) face ultimate completion within the next twenty-four months and therefore require recompete. Cellink operates as a 100% prime contractor with no subcontract footprint in the source data. The vendor competes exclusively through simplified acquisition procedures and full-and-open competitive purchase orders; no vehicle participation (GWAC, BPA, schedule) appears in the awards listed.